Physician

Edward M Mcintire, M.D.

According to 2025 Medicare claims, Edward Mcintire, M.D. (NPI: 1184689788) practices urology in the Cleveland, TN market, with the plurality of this provider's patient population coming from Bradley, TN. This provider's primary affiliated billing organization is TENNESSEE VALLEY UROLOGY CENTER PC (NPI: 1538173232; TIN: 62-0816934) and primary practice location at 37312-5288.

Mcintire's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 688 traditional Medicare patients, billed 8,141 HCPCS/CPT codes, and received $483,542 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,982 prescription claims across 644 beneficiaries totaling $6,190,829 in drug costs, led by Erleada (Apalutamide). DME data shows 98 claims. Open Payments data shows 38 records totaling $1,850. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $211,654 to $483,542. Similarly, Part D prescription costs have risen steadily, from $106,804 to $6,190,829. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $772 to $320.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	880	3,681	$211,654
2016	884	4,050	$224,268
2017	793	4,322	$283,338
2018	660	3,461	$273,779
2019	709	4,818	$234,824
2020	673	4,157	$175,361
2021	806	7,076	$253,869
2022	774	7,283	$387,474
2023	666	9,015	$376,925
2024	688	8,141	$483,542

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	494	1,735	$106,804
2016	486	1,783	$111,111
2017	461	1,749	$134,382
2018	444	1,694	$174,316
2019	473	1,813	$111,093
2020	498	1,794	$236,929
2021	614	2,110	$298,789
2022	636	2,338	$939,482
2023	618	2,505	$3,954,863
2024	644	2,982	$6,190,829

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	25	$3,379
2017	N/R	55	$12,285
2018	N/R	86	$21,247
2019	N/R	70	$18,809
2020	N/R	108	$27,261
2021	N/R	91	$28,113
2022	N/R	93	$14,918
2023	N/R	109	$27,156
2024	N/R	98	$43,598

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	450	742	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	250	409	$12
51798	Ultrasound measurement of bladder capacity after voiding	282	355	$7
81000	Manual urinalysis test with examination using microscope, non-automated	207	312	$4
81002	Urinalysis, manual test	363	497	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	214	6,755	$3,079,103
Xtandi	Enzalutamide	130	3,900	$1,782,674
Orgovyx	Relugolix	265	7,950	$694,091
Abiraterone Acetate	Abiraterone Acetate	57	1,710	$242,547
Nubeqa	Darolutamide	19	570	$237,245

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	19	$29,191
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	63	$14,087
A4332	Lubricant, individual sterile packet, each	N	N/R	16	$320

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$1,850	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Edward M. Mcintire, M.D.?

Tedicare shows public-source Medicare data for Edward M. Mcintire, M.D. (NPI 1184689788), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward M. Mcintire, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Edward M. Mcintire, M.D.?

Edward M. Mcintire, M.D. is linked to TENNESSEE VALLEY UROLOGY CENTER PC (billing NPI 1538173232) in the available physician profile data.

Does Edward M. Mcintire, M.D. have Open Payments data?

Edward M. Mcintire, M.D. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.